Fang Y. Wei - Publications

First-line pyrotinib plus apatinib in advanced non-small cell lung cancer harboring HER2 mutations or amplification: a phase II trial.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: May 20, 2026

Heterogeneous integrated III-V/Si laser with single-wavelength emission via longitudinal interference.

Journal: Optics express

Published: March 18, 2026

Adjuvant immunotherapy in resected non-small cell lung cancer harboring oncogenic driver alterations beyond EGFR and ALK: results from a retrospective analysis.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 02, 2026

Sub-1 dB loss and polarization-insensitive O-band edge coupler for standard single-mode fiber on a 300 mm silicon photonics platform.

Journal: Optics express

Published: February 20, 2026

Aumolertinib in non-small cell lung cancer with uncommon EGFR exon 19 deletions: a real-world dual-center study.

Journal: BMC cancer

Published: January 23, 2026

Recent advances in asymmetric bimetallic catalysis.

Journal: Chemical Society reviews

Published: November 19, 2025

Regulatory mechanism of the RNF168-SCCA1-MYH9 signaling axis in the response of ulcerative colitis.

Journal: Journal of gastroenterology

Published: November 12, 2025

Arbitrary frequency difference locking method for carrier in intersatellite coherent laser communication.

Journal: Optics express

Published: November 11, 2025

PODXL2 Promotes Cholangiocarcinoma Progression via Interactions with Ezrin and Activation of the MAPK/ERK1/2 and PI3K/AKT Signaling Pathways.

Journal: Digestive diseases and sciences

Published: November 07, 2025

Increase in soluble RAGE following intensive insulin therapy is associated with β-cell functional improvement and glycemic remission in newly diagnosed type 2 diabetes.

Journal: Journal of diabetes investigation

Published: November 05, 2025

Emerging technologies for early risk stratification and precision management of diabetic kidney disease: a multimodal framework integrating digital phenotypes and clinical biomarkers.

Journal: Frontiers in endocrinology

Published: October 19, 2025

Neomangiferin prolongs the lifespan of Caenorhabditis elegans by regulating autophagy-dependent IIS and MAPK pathways via bas-1.

Journal: Food & function

Published: September 09, 2025